Central serious choriorethinopathy (CSC)
Description:Central serious chorioretinopathy (CSC) is a pathology of the retina and the choroid characterized by the appearance of liquid under the retina. This liquid springs from a ‘leakage point’ located at the level of the retinal pigmentary epithelium.
It is the 4th most frequent retinal pathology. It mostly affects men (70% of cases), with an average age of 45. The disease springs from a general state of anxiety and is aggravated or triggered by the use of corticoids. Any general or local corticosteroid therapy should therefore be avoided for such patients at risk.
For women, the disease can be generated by pregnancy.
Symptoms:In case the macula is affected, patients experience visual impairment as well as the appearance of a rather dark cloud at the centre of their visual field (scotoma), image distortions (metamorphopsia) and modification in size and colour of perceived objects.
Evolution:In most cases, especially in the most frequent case of an acute CSC affecting a young patient, the pathology heals naturally in 1 to 4 months, without requiring any treatment.
After this period of time, if there is no amelioration, a treatment can be prescribed. Sometimes a treatment is prescribed earlier if the patient’s visual needs require it (for professional purposes for example).
CSC can recur in the following months or years.
Some forms of CSC recur and evolve through time, affecting both eyes. They therefore turn into a pathology called ‘Diffuse retinal epitheliopathy’ from which full recovery is not guaranteed.
Treatment:Treatment is considered in the absence of a spontaneous healing after 4 months of evolution.
- Photocoagulation of the leakage point or points noticed with the angiography if these points are outside the visual axis
- Visudyne photodynamic therapy
- Medical treatment with Eplerenone or Spironolactone
- Post-surgery instructions after vitreous and retinal surgery:
Download the PDF file (in French)
- Société Française d’Ophtalmologie:
- American Academy of Ophthalmology:
- ARVO: Association for Research in Vision and Ophthalmology:
- EVRS (European Vitreo Retinal Society):
- • Patient information from the SFO (in French):
- • Central Serious Chorioretinopathy (CSC):
- • SFO information on Fluorescein Angiography: